BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11685103)

  • 1. Regulation of glutathione redox status in lung and liver by conditioning regimens and keratinocyte growth factor in murine allogeneic bone marrow transplantation.
    Ziegler TR; Panoskaltsus-Mortari A; Gu LH; Jonas CR; Farrell CL; Lacey DL; Jones DP; Blazar BR
    Transplantation; 2001 Oct; 72(8):1354-62. PubMed ID: 11685103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Keratinocyte growth factor administered before conditioning ameliorates graft-versus-host disease after allogeneic bone marrow transplantation in mice.
    Panoskaltsis-Mortari A; Lacey DL; Vallera DA; Blazar BR
    Blood; 1998 Nov; 92(10):3960-7. PubMed ID: 9808590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclophosphamide prevents systemic keratinocyte growth factor-induced up-regulation of surfactant protein A after allogeneic transplant in mice.
    Yang S; Panoskaltsis-Mortari A; Ingbar DH; Matalon S; Zhu S; Resnik ER; Farrell CL; Lacey DL; Blazar BR; Haddad IY
    Am J Respir Crit Care Med; 2000 Nov; 162(5):1884-90. PubMed ID: 11069830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Keratinocyte growth factor facilitates alloengraftment and ameliorates graft-versus-host disease in mice by a mechanism independent of repair of conditioning-induced tissue injury.
    Panoskaltsis-Mortari A; Taylor PA; Rubin JS; Uren A; Welniak LA; Murphy WJ; Farrell CL; Lacey DL; Blazar BR
    Blood; 2000 Dec; 96(13):4350-6. PubMed ID: 11110712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An immunoablative regimen of fludarabine and cyclophosphamide prevents fully MHC-mismatched murine marrow graft rejection independent of GVHD.
    Petrus MJ; Williams JF; Eckhaus MA; Gress RE; Fowler DH
    Biol Blood Marrow Transplant; 2000; 6(2A):182-9. PubMed ID: 10816026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia.
    Hill GR; Teshima T; Gerbitz A; Pan L; Cooke KR; Brinson YS; Crawford JM; Ferrara JL
    J Clin Invest; 1999 Aug; 104(4):459-67. PubMed ID: 10449438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surfactant protein A is a required mediator of keratinocyte growth factor after experimental marrow transplantation.
    Haddad IY; Milla C; Yang S; Panoskaltsis-Mortari A; Hawgood S; Lacey DL; Blazar BR
    Am J Physiol Lung Cell Mol Physiol; 2003 Sep; 285(3):L602-10. PubMed ID: 12740217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KGF pretreatment decreases B7 and granzyme B expression and hastens repair in lungs of mice after allogeneic BMT.
    Panoskaltsis-Mortari A; Ingbar DH; Jung P; Haddad IY; Bitterman PB; Wangensteen OD; Farrell CL; Lacey DL; Blazar BR
    Am J Physiol Lung Cell Mol Physiol; 2000 May; 278(5):L988-99. PubMed ID: 10781430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The critical early proinflammatory events associated with idiopathic pneumonia syndrome in irradiated murine allogeneic recipients are due to donor T cell infusion and potentiated by cyclophosphamide.
    Panoskaltsis-Mortari A; Taylor PA; Yaeger TM; Wangensteen OD; Bitterman PB; Ingbar DH; Vallera DA; Blazar BR
    J Clin Invest; 1997 Sep; 100(5):1015-27. PubMed ID: 9276718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiol/redox metabolomic profiling implicates GSH dysregulation in early experimental graft versus host disease (GVHD).
    Suh JH; Kanathezhath B; Shenvi S; Guo H; Zhou A; Tiwana A; Kuypers F; Ames BN; Walters MC
    PLoS One; 2014; 9(2):e88868. PubMed ID: 24558439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Ringdén O; Labopin M; Tura S; Arcese W; Iriondo A; Zittoun R; Sierra J; Gorin NC
    Br J Haematol; 1996 Jun; 93(3):637-45. PubMed ID: 8652385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relapse after allogeneic bone marrow transplantation for refractory anemia is increased by shielding lungs and liver during total body irradiation.
    Anderson JE; Appelbaum FR; Schoch G; Barnett T; Chauncey TR; Flowers ME; Storb R
    Biol Blood Marrow Transplant; 2001; 7(3):163-70. PubMed ID: 11302550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High levels of peroxynitrite are generated in the lungs of irradiated mice given cyclophosphamide and allogeneic T cells. A potential mechanism of injury after marrow transplantation.
    Haddad IY; Panoskaltsis-Mortari A; Ingbar DH; Yang S; Milla CE; Blazar BR
    Am J Respir Cell Mol Biol; 1999 Jun; 20(6):1125-35. PubMed ID: 10340931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of acute graft-vs-host disease by a single low-dose cyclophosphamide injection following allogeneic bone marrow transplantation.
    Prigozhina TB; Elkin G; Khitrin S; Slavin S
    Exp Hematol; 2008 Dec; 36(12):1750-9. PubMed ID: 18809241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation.
    Min D; Taylor PA; Panoskaltsis-Mortari A; Chung B; Danilenko DM; Farrell C; Lacey DL; Blazar BR; Weinberg KI
    Blood; 2002 Jun; 99(12):4592-600. PubMed ID: 12036893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of etoposide, cyclophosphamide, and total body irradiation in allogeneic bone marrow transplantation for adult patients with hematological malignancies.
    Toubai T; Tanaka J; Mori A; Hashino S; Kobayashi S; Ota S; Miura Y; Kato N; Kahata K; Izumiyama K; Yonezumi M; Chiba K; Kondo T; Toyoshima N; Asaka M; Imamura M
    Clin Transplant; 2004 Oct; 18(5):552-7. PubMed ID: 15344959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A correlation between conditioning and engraftment in recipients of MHC-mismatched T cell-depleted murine bone marrow transplants.
    Soderling CC; Song CW; Blazar BR; Vallera DA
    J Immunol; 1985 Aug; 135(2):941-6. PubMed ID: 3891856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of diabetes in nonobese diabetic mice by nonmyeloablative allogeneic bone marrow transplantation.
    Elkin G; Prigozhina TB; Slavin S
    Exp Hematol; 2004 Jun; 32(6):579-84. PubMed ID: 15183899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Keratinocyte growth factor enhances glutathione redox state in rat intestinal mucosa during nutritional repletion.
    Jonas CR; Estívariz CF; Jones DP; Gu LH; Wallace TM; Diaz EE; Pascal RR; Cotsonis GA; Ziegler TR
    J Nutr; 1999 Jul; 129(7):1278-84. PubMed ID: 10395587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease.
    Miralbell R; Bieri S; Mermillod B; Helg C; Sancho G; Pastoors B; Keller A; Kurtz JM; Chapuis B
    J Clin Oncol; 1996 Feb; 14(2):579-85. PubMed ID: 8636774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.